IP Library Granted Patent US 10,434,251
Granted Patent B2
US 10,434,251 · App. 13/563,785 · Granted Oct 8, 2019

Multi-directional microfluidic drug delivery device

Inventors: PJ Anand (Ayer, MA); Deep Arjun Singh (Cambridge, MA)
Assignee: Alcyone Lifesciences, Inc.
A61M5/16804A61M25/0023A61B5/036A61B5/14503A61B5/4839A61M5/172A61M25/0026A61M2025/0042A61M2205/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,434,251
App. No.
13/563,785
Granted
Oct 8, 2019
Kind
B2
Abstract

The methods, systems, and devices disclosed herein generally involve convection-enhanced delivery of drugs to a target region within a patient. Microfluidic catheter devices are disclosed that are particularly suitable for targeted delivery of drugs via convection, including devices capable of multi-directional drug delivery, devices that control fluid pressure and velocity using the venturi effect, and devices that include conformable balloons. Methods of treating various diseases using such devices are also disclosed, including methods of treating cerebral and spinal cavernous malformations, cavernomas, and hemangiomas, methods of treating neurological diseases, methods of treatment using multiple microfluidic delivery devices, methods of treating hearing disorders, methods of spinal drug delivery using microfluidic devices, and methods of delivering stem cells and therapeutics during fetal surgery. Methods of manufacturing such devices are also disclosed.

Claims (33)

1. A microfluidic convection-enhanced-delivery (CED) device, comprising:

a body having a tip extending distally from the body and first and second legs extending proximally from the body;

a first channel extending along the first leg, across the body, and along the tip, the first channel having a first fluid outlet port disposed in a portion of the first channel that extends along the tip;

a second channel extending along the second leg, across the body, and along the tip, the second channel having a second fluid outlet port disposed in a portion of the second channel that extends along the tip; and

a nose that is disposed on a distal end of the body and that is cone-shaped, the tip of the body protruding distally beyond a vertex of the cone-shaped nose, the nose being configured to contact tissue when the device is inserted into said tissue,

wherein the legs, body, and tip are formed from a monolithic substrate and the first and second channels are formed on an outer surface of the monolithic substrate.

2. The device of claim 1 , wherein the body has a length of 1.5 mm.

3. The device of claim 1 , wherein the channels are formed from parylene.

4. The device of claim 1 , wherein the body, tip, and legs are formed from silicon.

5. The device of claim 1 , wherein the channels include 90 degree turns at their distal ends such that the outlet ports of the channels are aimed in a direction perpendicular to a longitudinal axis of the tip.

6. The device of claim 1 , further comprising a proximal catheter portion having a double-bore body in which first and second bores are formed, the first and second legs being disposed within the first and second bores of the double-bore body.

7. The device of claim 6 , further comprising first and second micro capillary tubes in fluid communication with the bores of the double-bore body.

8. The device of claim 6 , further comprising an adhesive that couples and seals the double-bore body to the first and second legs.

9. The device of claim 1 , wherein the nose has a maximum outside diameter of 1 mm to 1.5 mm.

10. The device of claim 1 , wherein the nose is formed from epoxy.

11. The device of claim 1 , wherein the nose is micro-machined.

12. The device of claim 1 , wherein the channels have a height of 10 microns.

13. The device of claim 1 , wherein the channels have a width of 20 microns.

14. The device of claim 1 , wherein the channels have a diameter of 20 microns.

15. The device of claim 1 , wherein the nose circumferentially surrounds the tip.

16. A microfluidic convection-enhanced-delivery (CED) device, comprising:

a body having a tip extending distally from the body and first and second legs extending proximally from the body;

a first channel extending along the first leg, across the body, and along the tip, the first channel having a first fluid outlet port disposed in a portion of the first channel that extends along the tip;

a second channel extending along the second leg, across the body, and along the tip, the second channel having a second fluid outlet port disposed in a portion of the second channel that extends along the tip; and

a nose that is disposed on a distal end of the body and that is cone-shaped, the tip of the body protruding distally beyond a vertex of the cone-shaped nose, the nose being configured to contact tissue when the device is inserted into said tissue,

wherein the legs, body, and tip are formed from a monolithic silicon substrate.

17. The device of claim 16 , further comprising a proximal catheter portion having a double-bore body in which first and second bores are formed, the first and second legs being disposed within the first and second bores of the double-bore body.

18. The device of claim 17 , further comprising first and second micro capillary tubes in fluid communication with the bores of the double-bore body.

19. The device of claim 17 , further comprising an adhesive that couples and seals the double-bore body to the first and second legs.

20. The device of claim 16 , wherein the nose has a maximum outside diameter of 1 mm to 1.5 mm.

21. The device of claim 16 , wherein the first and second legs are attached to the body at only one end of each of the first and second legs.

22. The device of claim 16 , wherein the first and second legs are separated from one another by a space therebetween.

23. The device of claim 16 , wherein the nose circumferentially surrounds the tip.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2025
From: ALCYONE THERAPEUTICS, INC.
To: NEELA THERAPEUTICS, INC.
Reel/Frame 072907/0553 →
CHANGE OF NAME Recorded Jan 13, 2022
From: ALCYONE LIFESCIENCES, INC.
To: ALCYONE THERAPEUTICS, INC.
Reel/Frame 058734/0707 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2014
From: ANAND, PJ; SINGH, DEEP ARJUN
To: ALCYONE LIFESCIENCES, INC.
Reel/Frame 033724/0667 →
Continuity (9)
Provisional Application 61615939 · Mar 27, 2012
Provisional Application 61513948 · Aug 1, 2011
Provisional Application 61513954 · Aug 1, 2011
Provisional Application 61513935 · Aug 1, 2011
Provisional Application 61513939 · Aug 1, 2011
Provisional Application 61513952 · Aug 1, 2011
Provisional Application 61513961 · Aug 1, 2011
Provisional Application 61513943 · Aug 1, 2011
Related Publication 20130035560A1 · Feb 7, 2013